Miyata S, Takemura G, Kosai K, Takahashi T, Esaki M, Li L, Kanamori H,
　Maruyama R, Goto K, Tsujimoto A, Takeyama  T, Kawaguchi T, Ohno T,
　Nishigaki K, Fujiwara T, Fujiwara H, Minatoguchi S.

　Anti-Fas Gene Therapy Prevents Doxorubicin-induced Acute Cardiotoxicity
　through Mechanisms Independent of Apoptosis.

　Am J Pathol. 176(2):687-98, 2010

　Mitsui K, Suzuki K, Aizawa E, Kawase E, Suemori H, Nakatsuji N, Mitani K.

　Gene targeting in human pluripotent stem cells with adeno-associated
　virus vectors.

　Biochem Biophys Res Commun. 388 711-7. 2009

　Kawasaki T, Saito K, Mitsui K, Ikawa M, Yamashita M, Taniguchi Y, Takeda S,
　Mitani K, Sakai N.

　Introduction of a foreign gene into zebrafish and medaka cells using
　adenoviral vectors.

　Zebrafish 6 253-8. 2009

Ijichi N, Ikeda K, Fujita M, Usui T, Urano T, Azuma K, Ouchi Y, Horie-Inoue K, and Inoue S.
EPAS1, a dexamethasone-inducible gene in osteoblasts, inhibits osteoblastic differentiation.

The Open Bone Journal. 1: 28-37, 2009

Kubo M, Ijichi N, Ikeda K, Horie-Inoue K, Takeda S, and Inoue S.
Modulation of adipogenesis-related gene expression by estrogen-related receptor γ during adipocytic differentiation.

Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms.1789: 71-77, 2009

Li L, Okada H, Takemura G, Kosai K, Kanamori H, Esaki M, Takahashi T, Goto K, Tsujimoto A, Maruyama R, Kawamura I, Kawaguchi T, Takeyama T, Fujiwara T, Fujiwara H, Minatoguchi S.

Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction.

Am J Physiol Heart Circ Physiol. 97(4):H1504-13. 2009

Umeno H, Chitose S, Murofushi Y, Kosai K, Sato K, Kawahara A, Nakashima T.

Efficacy of autologous fat injection laryngoplasty with an adenoviral vector expressing hepatocyte growth factor in a canine model.

J Laryngol Otol ;123,31:24-9. 2009

Okada H, Takemura G, Kosai K, Tsujimoto A, Esaki M, Takahashi T, Nagano S, Kanamori H, Miyata S,Li Y, Ohno T, Maruyama R, Ogino A, Li L, Nakagawa M, Nagashima K, Fujiwara T, Fujiwara H, Minatoguchi S.

Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.

Am J Physiol Heart Circ Physiol. 296(3):H616-26. 2009

Kondo T, Takemura G, Kosai K, Ohno T, Takahashi T, Esaki M, Goto K, Maruyama R, Murata I, Minatoguchi S, Fujiwra T, Fujiwara H.

Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.

Clin Exp Pharmacol Physiol. 35(11):1288-93. 2008

Esaki M, Takemura G, Kosai K, Takahashi T, Miyata S, Li L, Goto K, Maruyama R, Okada H, Kanamori H, Ogino A, Ushikoshi H, Minatoguchi S, Fujiwara T, Fujiwara H.

Treatment with an adenoviral vector encoding hepatosyte growth factor mitigates established cardiac dysfunction in doxorubicin –induced cardiomyopathy.

Am J Physiol Heart Circ Physiol. 294(2): H1048-1057, 2008